新活素(冻干重组人脑利钠肽)，本品适用于患有休息或轻微活动时呼吸困难的急性失代偿心力衰竭患者的静脉治疗。按NYHA分级大于Ⅱ级。
新型高效活能素 ZWFCNLY
The positive control drug (rhBNP) has relatively similar pharmacological and toxicological effects with those of the test drug, suggesting there is no significant toxicological difference between synthetic products and recombination products.
阳性对照药物(新活素)与受试药具有较为相近的药理毒理作用。 说明合成产品与重组产品并无明显毒理学差异。
参考来源 - 1.原藜芦碱A的毒性及其配伍研究 2.奈西立肽与冻干重组人脑利钠肽对食蟹猴的比较长期毒性研究·2,447,543篇论文数据，部分数据来源于NoteExpress
应用推荐